Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Ramalingam

Showing results (271-280 of 502) with videos related to

Pageof 51
Sort By:
Molecular Cancer Research : MCR|June 29, 2021
Membrane-Associated RING-CH 8 Functions as a Novel PD-L1 E3 Ligase to Mediate PD-L1 Degradation Induced by EGFR InhibitorsGuoqing Qian, Jianping Guo, Karin A Vallega, et al.
Lung Cancer (Amsterdam, Netherlands)|March 2, 2015
Predictors and outcomes of venous thromboembolism in hospitalized lung cancer patients: A Nationwide Inpatient Sample database analysisConor E Steuer, Madhusmita Behera, Sungjin Kim, et al.
Japanese Journal of Clinical Oncology|December 4, 2018
Osimertinib versus standard-of-care EGFR-TKI as first-line treatment for EGFRm advanced NSCLC: FLAURA Japanese subsetYuichiro Ohe, Fumio Imamura, Naoyuki Nogami, et al.
Targeted Oncology|February 5, 2021
Osimertinib Versus Comparator EGFR TKI as First-Line Treatment for EGFR-Mutated Advanced NSCLC: FLAURA China, A Randomized StudyYing Cheng, Yong He, Wei Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2010
Phase I pharmacokinetic and pharmacodynamic study of 17-dimethylaminoethylamino-17-demethoxygeldanamycin, an inhibitor of heat-shock protein 90, in patients with advanced solid tumorsRamesh K Ramanathan, Merrill J Egorin, Charles Erlichman, et al.
Lung Cancer (Amsterdam, Netherlands)|May 20, 2015
A phase 1 safety study of veliparib combined with cisplatin and etoposide in extensive stage small cell lung cancer: A trial of the ECOG-ACRIN Cancer Research Group (E2511)Taofeek K Owonikoko, Suzanne E Dahlberg, Saad A Khan, et al.
The Oncologist|March 28, 2025
Incidence and correlates of high-grade chemotherapy-induced peripheral neuropathy in patients with lung cancerMitchell S von Itzstein, Sawsan Rashdan, Suzanne E Dahlberg, et al.
Cell Reports. Medicine|May 18, 2022
Distinct phenotypic states and spatial distribution of CD8<sup>+</sup> T cell clonotypes in human brain metastasesLisa J Sudmeier, Kimberly B Hoang, Edjah K Nduom, et al.
Plos One|August 19, 2021
Expression of tdTomato and luciferase in a murine lung cancer alters the growth and immune microenvironment of the tumorLei Huang, Ramireddy Bommireddy, Luis E Munoz, et al.
Cancer|October 7, 2015
Trends, predictors, and impact of systemic chemotherapy in small cell lung cancer patients between 1985 and 2005Madhusmita Behera, Camille Ragin, Sungjin Kim, et al.
Pageof 51

Showing results (271-280 of 502) with videos related to

Sort By:
Pageof 51
Molecular Cancer Research : MCR|June 29, 2021
Membrane-Associated RING-CH 8 Functions as a Novel PD-L1 E3 Ligase to Mediate PD-L1 Degradation Induced by EGFR InhibitorsGuoqing Qian, Jianping Guo, Karin A Vallega, et al.
Lung Cancer (Amsterdam, Netherlands)|March 2, 2015
Predictors and outcomes of venous thromboembolism in hospitalized lung cancer patients: A Nationwide Inpatient Sample database analysisConor E Steuer, Madhusmita Behera, Sungjin Kim, et al.
Japanese Journal of Clinical Oncology|December 4, 2018
Osimertinib versus standard-of-care EGFR-TKI as first-line treatment for EGFRm advanced NSCLC: FLAURA Japanese subsetYuichiro Ohe, Fumio Imamura, Naoyuki Nogami, et al.
Targeted Oncology|February 5, 2021
Osimertinib Versus Comparator EGFR TKI as First-Line Treatment for EGFR-Mutated Advanced NSCLC: FLAURA China, A Randomized StudyYing Cheng, Yong He, Wei Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2010
Phase I pharmacokinetic and pharmacodynamic study of 17-dimethylaminoethylamino-17-demethoxygeldanamycin, an inhibitor of heat-shock protein 90, in patients with advanced solid tumorsRamesh K Ramanathan, Merrill J Egorin, Charles Erlichman, et al.
Lung Cancer (Amsterdam, Netherlands)|May 20, 2015
A phase 1 safety study of veliparib combined with cisplatin and etoposide in extensive stage small cell lung cancer: A trial of the ECOG-ACRIN Cancer Research Group (E2511)Taofeek K Owonikoko, Suzanne E Dahlberg, Saad A Khan, et al.
The Oncologist|March 28, 2025
Incidence and correlates of high-grade chemotherapy-induced peripheral neuropathy in patients with lung cancerMitchell S von Itzstein, Sawsan Rashdan, Suzanne E Dahlberg, et al.
Cell Reports. Medicine|May 18, 2022
Distinct phenotypic states and spatial distribution of CD8<sup>+</sup> T cell clonotypes in human brain metastasesLisa J Sudmeier, Kimberly B Hoang, Edjah K Nduom, et al.
Plos One|August 19, 2021
Expression of tdTomato and luciferase in a murine lung cancer alters the growth and immune microenvironment of the tumorLei Huang, Ramireddy Bommireddy, Luis E Munoz, et al.
Cancer|October 7, 2015
Trends, predictors, and impact of systemic chemotherapy in small cell lung cancer patients between 1985 and 2005Madhusmita Behera, Camille Ragin, Sungjin Kim, et al.
Pageof 51